1. Home
  2. CPHI vs CVM Comparison

CPHI vs CVM Comparison

Compare CPHI & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

N/A

Current Price

$0.65

Market Cap

32.3M

Sector

Health Care

ML Signal

N/A

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

N/A

Current Price

$2.10

Market Cap

30.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CPHI
CVM
Founded
N/A
1983
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.3M
30.1M
IPO Year
2008
1996

Fundamental Metrics

Financial Performance
Metric
CPHI
CVM
Price
$0.65
$2.10
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $12.50
AVG Volume (30 Days)
★ 209.9K
98.3K
Earning Date
11-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $4,144,268.00
$264,033.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 65.45
52 Week Low
$0.38
$0.89
52 Week High
$19.19
$10.83

Technical Indicators

Market Signals
Indicator
CPHI
CVM
Relative Strength Index (RSI) 40.28 76.37
Support Level $0.53 $0.95
Resistance Level $0.68 $4.73
Average True Range (ATR) 0.06 0.10
MACD 0.01 0.04
Stochastic Oscillator 14.55 95.38

Price Performance

Historical Comparison
CPHI
CVM

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: